Results 131 to 140 of about 12,722 (201)

Under a Spell: Neurologic Evaluation of Presyncope as a Feature of Dysautonomia. [PDF]

Biomedicines
Blitshteyn S, Chémali KR, Lau DH.
europepmc   +1 more source

Functional and cognitive recovery after intensive care unit-initiated intensive rehabilitation in anti-N-methyl-D-aspartate receptor encephalitis: A long-term case report. [PDF]

Medicine (Baltimore)
Cho Y, Park H, Kim YS, Byun H.
europepmc   +1 more source

Multiple System Atrophy Without Dysautonomia: An Autopsy-Confirmed Study. [PDF]

Neurology
Wilkens I, Bebermeier S, Heine J, Ruf VC, Compta Y, Molina Porcel L, Troakes C, Vamanu A, Downes S, Irwin DJ, Cohen J, Lee EB, Nilsson CF, Englund EM, Nemati M, Katzdobler S, Levin J, Bernhardt AM, Pantelyat A, Seemiller J, Berger S, Van Swieten JC, Dopper EGP, Rozemuller AJM, Kovacs GG, Bendahan N, Lang AE, Herms J, Höglinger GU, Hopfner F.   +29 more
europepmc   +1 more source

Gastrointestinal Dysautonomia: A Rare Immune-Related Adverse Event That Requires Early Recognition and High-Dose Immunosuppression. [PDF]

Cureus
Norton B, Sennfalt S, Nortley R, Hill P, Nathan P, Iodice V, Zarate-Lopez N, Carr A.   +7 more
europepmc   +1 more source

ELP1 gene augmentation restores visual function in a mouse model of familial dysautonomia. [PDF]

Mol Ther
Cheng HC, Koli S, Lewis K, Ketchale S, Anvarinia Y, Erdoes M, Liu Y, Keiper CE, Estelien R, Chagnon M, Vandenberghe LH, Gao D, Lefcort F, Morini E, Slaugenhaupt SA, Chekuri A.   +15 more
europepmc   +1 more source

Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid^® in a Long COVID cohort: a case series. [PDF]

Front Immunol
Pridgen WL, Putrino D.
europepmc   +1 more source

Long-term potentiation and neurotransmitters expression and segregation are altered in the Metabolic Syndrome-associated dysautonomia. [PDF]

PLoS One
Elinos D, Veladiz-Gracia F, González-Sierra C, Rubio-Galicia A, Cifuentes F, Morales MA.   +5 more
europepmc   +1 more source